The Bw4/Bw6 difference between HLA-B(*)0802 and HLA-B(*)0801 changes the peptides endogenously bound and the stimulation of alloreactive T cells

Immunogenetics

Volumn 48, Issue 1, 1998, Pages 56-61

  Arnett, Kelly L ^a   Huang, Wen ^a   Valiante, Nicholas M ^a   Barber, Linda D ^a   Parham, Peter ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Alloreactivity; Endogenous peptide; HLA B8 subtypes; Peptide binding specificity

Indexed keywords

HLA B ANTIGEN;

ALLOIMMUNITY; AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EVOLUTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; CELL LINE; HLA-B ANTIGENS; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0031838030     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050400     Document Type: Article

References (19)

1. Arnett, K.L., Adams, E.J., Gumperz, J.E., Darke, C., Marsh, S.G.E., Gelsthorpe, K., and Parham, P. Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802]. Tissue Antigens 46: 316-321, 1995
2. Barber, L.D., Gillece-Castro, B., Percival, L., Li, X., Clayberger, C., and Parham, P. Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr Biol 5: 179-190, 1995
3. Bodmer, J.G., Marsh, S.G., Albert, E.D., Bodmer, W.F., Bontrop, R.E., Charron, D., Dupont, B., Erlich, H.A., Fauchet, R., Mach, B., Mayr, W.R., Parham, P., Sasazuki, T., Schreuder, G.M., Strominger, J.L., Svejgaard, A., and Terasaki, P.I. Nomenclature for factors of the HLA System, 1996. Hum Immunol 53: 98-128, 1997
4. Brodsky, F.M. and Parham, P. Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J Immunol 128: 129-135, 1982
5. Cella, M., Longo, A., Ferrara, G.B., Strominger, J.L., and Colonna, M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 180: 1235-1242, 1994
6. DiBrino, M., Parker, K.C., Shiloach, J., Turner, R.V., Tsuchida, T., Garfield, M., Biddison, W.E., and Coligan, J.E. Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8. J Immunol 152: 620-31, 1994
7. Gumperz, J.E., Litwin, V., Phillips, J.H., Lanier, L.L., and Parham, P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 181: 1133-1144, 1995
8. Gumperz, J.E., Barber, L.D., Valiante, N.M., Percival, L., Phillips, J.H., Lanier, L.L., and Parham, P. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions in recognition by the NKB1 killer cell inhibitory receptor. J Immunol 158: 5237-5241, 1997
9. Hill, A.V.S., Elvin, J., Willis, A.C., Aidoo, M. Allsopp, C.E.M., Gotch, F.M., Gao, X.M., Takiguchi, M., Greenwood, B.M., Townsend, A.R.M., McMichael, A.J., and Whittle, H.C. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360: 434-439, 1992
10. Imanishi, T., Akaza, T., Kimura, A., Tokunaga, K., and Gojobori, T. W15.1: allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In K. Tsuji, M. Aizawa, and T. Sasazuki (eds.): HLA 1991, Proceedings of the Eleventh International Histocompatibility Workshop and Conference (Vol 1), pp. 1065-1220, Oxford University Press, Oxford, 1992
11. Malcherek, G., Falk, G., Rötzschke, O., Rammensee, H.-G., Stevanović, S., Gnau, V., Jung, G., and Melms, A. Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis. Int Immunol 5: 1229-1237, 1993
12. Parham, P., Arnett, K.L., Adams, E.J., Little, A.-M., Tees, K., Barber, L.D., Marsh, S.G.E., Ohta, T., Markow, T., and Petzl-Erler, M. Episodic evolution and turnover of HLA-B alleles in the indigenous populations of the new world. Tissue Antigens 50: 219-232, 1997
13. Phillips, R.E., Rowland-Jones, S., Nixon, D.F., Gotch, F.M., Edwards, J. P., Ogunlesi, A.O., Elvin, J.G., Rothbard, J.A., Bangham, C.R., and Rizza, C.R. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354: 453-459, 1991
14. Rammensee, H.-G., Friede, T., and Stevanović, S. MHC ligands and peptide motifs: first listing. Immunogenetics 41: 178-228, 1995
15. Reid, S.W., McAdam, S., Smith, K.J., Klenerman, P., O'Callaghan, C.A., Harlos, K., Jakobsen, B.K., McMichael, A.J., Bell, J.I., Stuart, D.I., and Jones, E.Y. Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J Exp Med 184: 2279-86, 1996
16. Smith, K.J., Reid, S.W., Harlos, K., McMichael, A.J., Stuart, D.I., and Bell, J.I. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity 4: 215-228, 1996a
17. Smith, K.J., Reid, S.W., Stuart, D.I., McMichael, A.J., Jones, E.Y., and Bell, J.I. An altered position of the α2 helix is revealed by the crystal structure of HLA-B*3501. Immunity 4: 203-213, 1996b
18. Sutton, J., Rowland-Jones, S., Rosenberg, W., Nixon, D., Gotch, F., Gao, X.M., Murray, N., Spoonas, A., Driscoll, P., and Smith, M. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides. Eur J Immunol 23: 447-453, 1993
19. Taylor, G.A., Lai, W.S., Oakey, R.J., Seldin, M.F., Shows, T.B., Eddy, R.L.J., and Blackshear, P.J. The human TTP protein: sequence, alignment with related proteins, and chromosomal localization of the mouse and human genes. Nucleic Acids Res 19: 3454, 1991